We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSI
2501
DELISTED
Vitamin Shoppe Inc.
VSI
$60K ﹤0.01%
15,300
DRRX
2502
DELISTED
DURECT Corp
DRRX
$59K ﹤0.01%
8,994
-252
-3% -$1.57K
CRR
2503
DELISTED
Carbo Ceramics Inc.
CRR
$59K ﹤0.01%
43,700
-345
-0.8% -$762
III icon
2504
Information Services Group
III
$249M
$58K ﹤0.01%
18,462
GBR icon
2505
New Concept Energy
GBR
$3.69M
$56K ﹤0.01%
30,600
LRMR icon
2506
Larimar Therapeutics
LRMR
$454M
$56K ﹤0.01%
3,901
-42
-1% -$1.12K
HTZ.RT
2507
DELISTED
Hertz Global Holdings
HTZ.RT
$56K ﹤0.01%
+28,737
New +$63.7K
OCC icon
2508
Optical Cable Corp
OCC
$149M
$53K ﹤0.01%
12,869
ASNA
2509
DELISTED
Ascena Retail Group, Inc.
ASNA
$53K ﹤0.01%
4,368
+25
+0.6% +$530
DF
2510
DELISTED
Dean Foods Company
DF
$53K ﹤0.01%
56,883
+100
+0.2% +$161
OTIC
2511
DELISTED
Otonomy, Inc.
OTIC
$51K ﹤0.01%
18,700
SALM
2512
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$50K ﹤0.01%
20,450
BFX
2513
DELISTED
BowFlex Inc.
BFX
$46K ﹤0.01%
21,000
-504
-2% -$1.99K
PXLW icon
2514
Pixelworks
PXLW
$42.3M
$45K ﹤0.01%
1,267
ENZ
2515
DELISTED
Enzo Biochem, Inc.
ENZ
$45K ﹤0.01%
13,443
+100
+0.7% +$352
AMPE
2516
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$44K ﹤0.01%
377
-5
-1% -$792
CVIA
2517
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$44K ﹤0.01%
22,384
+4,096
+22% +$15.8K
AWRE icon
2518
Aware
AWRE
$26M
$40K ﹤0.01%
12,000
INO icon
2519
Inovio Pharmaceuticals
INO
$79.6M
$40K ﹤0.01%
1,143
HOS
2520
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$40K ﹤0.01%
31,800
ZN
2521
DELISTED
Zion Oil & Gas, Inc.
ZN
$39K ﹤0.01%
117,600
-1,032
-0.9% -$558
BW icon
2522
Babcock & Wilcox
BW
$1.46B
$38K ﹤0.01%
11,210
-38
-0.3% -$147
LYTS icon
2523
LSI Industries
LYTS
$890M
$38K ﹤0.01%
10,325
QHC
2524
DELISTED
Quorum Health Corporation
QHC
$37K ﹤0.01%
26,815
-468
-2% -$768
ACGN
2525
DELISTED
Aceragen Inc
ACGN
$27K ﹤0.01%
601
-14
-2% -$662

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.